Interrelationship between Daytime Functional Outcomes and Psychological Distress in Patients with Obstructive Sleep Apnea: A Cross-Sectional Study Authors: Khue Bui-Diem, Nguyen Van Tho, Thu Nguyen-Binh, Quynh Doan-Truc, Sy Duong-Quy Published: 2026 ABSTRACT IntroductionObstructive sleep apnea (OSA) is associated with decreased daytime functional outcomes and increased psychological stress. However, the specific profile of this burden, particularly in the Vietnamese population, remains understudied. This study aimed to analyze sleep-related functional outcomes and psychological stress in a population of untreated Vietnamese patients with OSA.MethodsWe conducted a cross-sectional study of 61 untreated patients with OSA (78.7% male, mean age 47.8 ± 12.9 years). Participants completed the 10-item Functional Outcomes of Sleep Questionnaire (FOSQ-10) and the 21-item Depression, Anxiety, and Stress Scale (DASS-21). Descriptive statistics, Spearman correlation coefficients, and a generalized linear model were used to assess the prevalence of symptoms and the relationship between functional and psychological domains.ResultsThe majority of the study population presented with severe OSA (mean apnea–hypopnea index [AHI], 47.5 ± 25.5 events/h). The median total score for FOSQ-10 was 16.3 (interquartile range [IQR]: 14.0–18.3). A notable finding was the high prevalence of clinically significant (moderate or higher) psychological distress, including depression, anxiety, and stress (22.9%, 54.1%, and 18.0%, respectively). Multivariate regression demonstrated that age was positively associated with FOSQ-10 general productivity but negatively associated with intimacy, whereas AHI was negatively associated with intimacy. FOSQ-10 and DASS-21 scores showed consistent negative correlations across all domains, indicating that diminished sleep-related functional quality of life correlates with elevated psychological distress.ConclusionsIn untreated Vietnamese patients with OSA, the prevalence of psychological discomfort, especially anxiety, is considerable and is associated with significant functional impairment. The substantial association between low functional quality of life and high levels of psychological distress shows how important it is to do thorough baseline examinations. Routine assessment for functional impairment and psychological distress should be integral components of the clinical evaluation for patients with OSA. Key Summary Points Obstructive sleep apnea (OSA) causes impaired daytime functioning and increased psychological distress, but the specific characteristics of this burden in Vietnamese patients have not been fully studied.This study aimed to find the relationship between sleep-related daytime functional outcomes and psychological distress in untreated Vietnamese patients with OSA.Results showed that patients with OSA had significant impairment in daytime functioning and faced a high rate of moderate-to-severe psychological symptoms, particularly anxiety, which accounted for 54.1%.The significant connection between functional quality of life and psychological discomfort suggests that the impact of OSA extends beyond nighttime respiratory events to include mental health.Routine screening for functional impairments and psychological distress should be included as an essential component of the clinical assessment for patients with OSA. Obstructive sleep apnea (OSA) causes impaired daytime functioning and increased psychological distress, but the specific characteristics of this burden in Vietnamese patients have not been fully studied.This study aimed to find the relationship between sleep-related daytime functional outcomes and psychological distress in untreated Vietnamese patients with OSA.Results showed that patients with OSA had significant impairment in daytime functioning and faced a high rate of moderate-to-severe psychological symptoms, particularly anxiety, which accounted for 54.1%.The significant connection between functional quality of life and psychological discomfort suggests that the impact of OSA extends beyond nighttime respiratory events to include mental health.Routine screening for functional impairments and psychological distress should be included as an essential component of the clinical assessment for patients with OSA. Introduction OSA is characterized by intermittent airway obstruction or narrowing during sleep, which disrupts sleep and reduces blood oxygen levels, consequently impairing daytime function and affecting a patient’s mental well-being. The Functional Outcomes of Sleep Questionnaire (FOSQ) is a commonly used tool for assessing daytime sleepiness and quality of life in patients with OSA. The FOSQ evaluates how sleepiness interferes with daily activities across five domains: activity level, vigilance, intimacy/sexual relationships, general productivity, and social outcomes. Given that the original 30-item FOSQ is lengthy and less practical for large-scale or longitudinal research, a shortened version, the FOSQ-10, was developed in 2009. The 10-item FOSQ was evaluated as having similar effectiveness to the 30-item FOSQ in patient assessment [1], with an internal consistency of α = 0.87, a correlation between the two questionnaires before treatment of r = 0.96 and after 3 months of continuous positive airway pressure (CPAP) treatment of r = 0.97 (p < 0.0001). In clinical practice, a total score of ≥ 17.9 is commonly used as a threshold for normal sleep-related quality of life. The FOSQ-10 has been studied for reliability and validity in the Vietnamese population [2]. Studies by Chaiyaporn-tanarat et al., 2024 [3], Soose et al., 2016 [4], Veje et al., 2021 [5], and Xu et al., 2024 [6] all showed low FOSQ-10 scores in patients with OSA, as well as improvement after treatment. Psychological states are intricately linked to sleep quality. DASS is a set of three self-reported scales designed to measure negative emotional states, such as depression, anxiety, and stress. The full version of the DASS scale includes 42 questions, making it difficult to use in clinical research and evaluation. DASS-21, established in 1998, has seven questions per scale. In addition to being concise and easy to use, this shortened version is considered to have several advantages over the full version because it includes fewer questions, a clearer structure, and less interaction between elements [7, 8]. The 21-item Depression, Anxiety, and Stress Scale (DASS-21) provides a validated framework for assessing these emotional states and has demonstrated strong structural validity and normative data across diverse populations [8]. The scale has been translated and validated in a Vietnamese population, including rural women and adolescents [9, 10]. Results from a cross-sectional study suggest that patients with depression, with or without comorbid OSA, report poorer functional outcomes than those with OSA alone [11]. In addition, the Sydney Sleep Biobank reported that higher depressive symptoms (by DASS-21 grouping) were associated with worse FOSQ-10 scores (lower function) [12]. In the present study, the combined use of the FOSQ-10 and DASS-21, together with polysomnography (PSG) parameters, such as the apnea–hypopnea index (AHI), nadir SpO2, and percentage of sleep time with SpO2 < 90% (T90), enabled a comprehensive evaluation of both subjective functional impairment and psychological distress in patients with OSA. This integrated approach facilitates a better understanding of how disease severity relates to patients’ daytime functioning and emotional well-being. Accordingly, this study aimed to (1) characterize sleep-related functional impairment using the FOSQ-10 and (2) assess the prevalence and severity of psychological distress using the DASS-21 in untreated Vietnamese patients with OSA, while exploring their interrelationships within the clinical context of PSG-defined disease severity. Methods Study Design and Participants A cross-sectional study was conducted between November 2022 and August 2024 at the University Medical Center Ho Chi Minh City, Vietnam, a major tertiary referral hospital. The study population comprised 61 treatment-naïve outpatients diagnosed with obstructive sleep apnea (OSA) via standardized polysomnography (PSG). The inclusion criteria focused on newly diagnosed individuals who had not yet initiated any form of therapy. Patients were excluded if they had a history of OSA treatment (e.g., CPAP or surgery), other sleep disorders besides OSA, uncontrolled severe comorbidities (that would significantly impair the patient’s functional status and ability to complete the assessments), inability to complete the mandatory questionnaires, or were pregnant. The participant selection process is summarized in Fig. 1. A sample size of n = 61 was evaluated for precision using a margin-of-error approach. Based on a standard deviation of 3.23 for the FOSQ-10 total score, as reported in the instrument’s development study [1], a sample of 61 participants provides a margin of error of approximately ±0.81 points at a 95% confidence level.Fig. 1Patient recruitment flowchart. OSA obstructive sleep apnea Patient recruitment flowchart. OSA obstructive sleep apnea The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board of the University of Medicine and Pharmacy at Ho Chi Minh City (approval no. 657/HDDD-DHYD, dated 18 August 2022). Written informed consent was obtained from all participants. Clinical and Subjective Assessments At baseline, participants completed two primary self-report instruments to quantify functional impairment and emotional status. Firstly, Functional Outcomes of Sleep Questionnaire-10 (FOSQ-10) is a validated instrument that measures the impact of excessive sleepiness on daily functional capacity across five domains: general productivity, activity level, vigilance, social outcomes, and intimacy/sexual relationships. Responses are recorded on a 4-point Likert scale (1 = extreme difficulty, 4 = no difficulty). A total score of ≥ 17.9 is considered the threshold for normal sleep-related quality of life. Secondly, the 21-item Depression, Anxiety, and Stress Scale (DASS-21) was used to assesses the severity of three core negative emotional states: depression (D), anxiety (A), and stress (S). Each subscale comprises seven items. Final scores were multiplied by two to ensure comparability with the original 42-item scale. Clinically significant symptoms (moderate or higher) were identified using established cutoff points: depression ≥ 14, anxiety ≥ 10, and stress ≥ 19. The FOSQ-10 and DASS-21 have been validated for use in Vietnam [2, 9, 10]. The FOSQ-10 was used with permission from Weaver [2]. The DASS-21 is a public domain instrument and was used in accordance with the established guidelines for academic research. Body mass index (BMI) was classified according to Asian-specific criteria, with obesity defined as ≥ 25 kg/m2 [13]. Data Management and Statistical Analysis Data were entered and managed using EpiData software to ensure data integrity and minimize entry errors. All statistical analyses were performed using R software (version 4.5.2; R Foundation for Statistical Computing, Vienna, Austria) within the RStudio integrated development environment. Continuous variables are expressed as mean ± standard deviation (SD) for normally distributed data or as median (interquartile range [ IQR]) for non-normally distributed data. Categorical variables are reported as frequencies (n) and percentages (%). Spearman’s correlation coefficient (rho) was utilized to assess the relationships between FOSQ-10 functional domains and DASS-21 psychological components. To evaluate the associations between PSG parameters and FOSQ-10 scores, univariate generalized linear models (GLMs) with a gamma distribution and log-link function were fitted. Each factor was entered separately into the model for each outcome, and effect ratios (exp[β]) with corresponding 95% confidence intervals were reported. This model was selected to account for the positive, right-skewed nature and heteroscedasticity of the data. Statistical significance was established at a two-tailed p < 0.05. Results Demographic and Polysomnographic Characteristics In total, 61 patients with obstructive sleep apnea (OSA) were enrolled in this study (Fig. 1). The characteristics of the study population are summarized in Table 1.Table 1Demographic and polysomnographic characteristics of the study populationCharacteristicTotal (N = 61)Male (N = 48)Female (N = 13)p-Value*Age (years), mean ± SD47.8 ± 12.946.9 ± 13.351.3 ± 11.40.245Sex, n (%)Male48 (78.7)Female13 (21.3)BMI (kg/m2), mean ± SD28.4 ± 5.128.5 ± 4.528.1 ± 7.10.878Obesity (BMI > 25 kg/m2), n (%)48 (78.7)40 (83)8 (62)0.126Neck circumference (cm), mean ± SD40.1 ± 4.241.4 ± 3.635.5 ± 3.1< 0.001Waist circumference (cm), mean ± SD98.7 ± 14.6100.5 ± 14.292.2 ± 14.80.087Total sleep time (h), mean ± SD6.3 ± 1.16.2 ± 1.16.6 ± 1.20.266Sleep efficiency (%), mean ± SD79.2 ± 10.979.2 ± 10.979.2 ± 11.2> 0.999AHI (events/h), mean ± SD47.5 ± 25.551.2 ± 26.133.9 ± 18.50.011OSA severity, n (%)0.029Mild3 (4.9)3 (6.3)0 (0)Moderate15 (24.6)8 (17)7 (54)Severe43 (70.5)37 (77)6 (46)Nadir SpO2 (%), mean ± SD72.3 ± 10.671.8 ± 10.574.3 ± 11.20.469T90 (%), median (IQR)5.7 (1.4–20.7)9.3 (3.0–29.8)0.9 (0.0–4.5)0.015BMI body mass index (classification of obesity according to Asian individuals), AHI apnea–hypopnea index, OSA obstructive sleep apnea, T90 the percentage of sleep time spent with SpO2 < 90%*Welch’s two-sample t-test; Fisher’s exact test; Wilcoxon rank-sum test (comparison of male and female individuals) Table 1Demographic and polysomnographic characteristics of the study populationCharacteristicTotal (N = 61)Male (N = 48)Female (N = 13)p-Value*Age (years), mean ± SD47.8 ± 12.946.9 ± 13.351.3 ± 11.40.245Sex, n (%)Male48 (78.7)Female13 (21.3)BMI (kg/m2), mean ± SD28.4 ± 5.128.5 ± 4.528.1 ± 7.10.878Obesity (BMI > 25 kg/m2), n (%)48 (78.7)40 (83)8 (62)0.126Neck circumference (cm), mean ± SD40.1 ± 4.241.4 ± 3.635.5 ± 3.1< 0.001Waist circumference (cm), mean ± SD98.7 ± 14.6100.5 ± 14.292.2 ± 14.80.087Total sleep time (h), mean ± SD6.3 ± 1.16.2 ± 1.16.6 ± 1.20.266Sleep efficiency (%), mean ± SD79.2 ± 10.979.2 ± 10.979.2 ± 11.2> 0.999AHI (events/h), mean ± SD47.5 ± 25.551.2 ± 26.133.9 ± 18.50.011OSA severity, n (%)0.029Mild3 (4.9)3 (6.3)0 (0)Moderate15 (24.6)8 (17)7 (54)Severe43 (70.5)37 (77)6 (46)Nadir SpO2 (%), mean ± SD72.3 ± 10.671.8 ± 10.574.3 ± 11.20.469T90 (%), median (IQR)5.7 (1.4–20.7)9.3 (3.0–29.8)0.9 (0.0–4.5)0.015BMI body mass index (classification of obesity according to Asian individuals), AHI apnea–hypopnea index, OSA obstructive sleep apnea, T90 the percentage of sleep time spent with SpO2 < 90%*Welch’s two-sample t-test; Fisher’s exact test; Wilcoxon rank-sum test (comparison of male and female individuals) Demographic and polysomnographic characteristics of the study population BMI body mass index (classification of obesity according to Asian individuals), AHI apnea–hypopnea index, OSA obstructive sleep apnea, T90 the percentage of sleep time spent with SpO2 < 90% *Welch’s two-sample t-test; Fisher’s exact test; Wilcoxon rank-sum test (comparison of male and female individuals) The mean age was 47.8 ± 12.9 years, with the 46–55- and > 55-year age groups representing the largest proportions (29.5% each). The sample was predominantly male (78.7%). The mean body mass index (BMI) was 28.4 ± 5.1 kg/m2, with 78.7% of patients classified as obese (BMI > 25). Polysomnography (PSG) revealed severe OSA in the majority of the population, with a mean apnea–hypopnea index (AHI) of 47.5 ± 25.5 events/h. Specifically, 70.5% of patients had severe OSA (AHI ≥ 30), while mild and moderate cases accounted for 4.9% and 24.6%, respectively. Significant nocturnal hypoxemia was observed, with a mean nadir SpO2 of 72.3 ± 10.6% and a median T90 of 5.7%. Male patients exhibited significantly more severe OSA than female patients, characterized by a higher mean AHI (p = 0.011) and a greater proportion of severe cases (p = 0.029). Additionally, men had significantly larger neck circumferences (p < 0.001) and more prolonged nocturnal desaturation, with a notably higher T90 compared with women (p = 0.015). Comorbidities The study population exhibited a diverse range of self-reported medical histories, with gastroesophageal reflux disease (54.1%), dyslipidemia (50.8%), and upper respiratory conditions (sinusitis and tonsillitis, 47.5%) being the most prevalent. Regarding cardiometabolic health, hypertension was common (41%), while diabetes mellitus and stroke were reported by 9.8% and 3.3% of participants, respectively. Notably, mental health conditions were significant within the population, with anxiety disorders affecting 19.7% of the population and depression reported in 6.6%. Other chronic conditions, such as asthma, chronic obstructive pulmonary disease (COPD), and hypothyroidism, occurred at lower frequencies. Subjective Daytime Sleepiness and Functional Outcomes (FOSQ-10) The impact of OSA on daily functioning was assessed using the FOSQ-10 (Table 2).Table 2Pretreatment FOSQ-10 scores (n = 61)FOSQ-10 domainTotal (N = 61)aMale (N = 48)aFemale (N = 13)ap-Value*General productivity3.0 (2.5–4.0)3.0 (2.5–4.0)3.0 (2.0–3.5)0.420Activity level3.3 (2.3–3.7)3.2 (2.2–3.7)3.7 (3.0–4.0)0.029Vigilance3.3 (2.7–3.7)3.3 (2.7–3.7)3.0 (3.0–3.3)0.922Social outcomes3.0 (3.0–4.0)3.0 (2.0–4.0)4.0 (3.0–4.0)0.269Intimacy and sexual relationships3.0 (2.0–4.0)3.5 (2.0–4.0)3.0 (1.0–4.0)0.381Mean FOSQ score3.3 (2.8–3.7)3.3 (2.8–3.6)3.2 (2.8–3.8)0.718Total FOSQ score16.3 (14.0–18.3)16.3 (13.8–18.2)16.0 (14.0–18.8)0.718aMedian (IQR)*Wilcoxon rank-sum testFOSQ-10 10-item Functional Outcomes of Sleep Questionnaire Table 2Pretreatment FOSQ-10 scores (n = 61)FOSQ-10 domainTotal (N = 61)aMale (N = 48)aFemale (N = 13)ap-Value*General productivity3.0 (2.5–4.0)3.0 (2.5–4.0)3.0 (2.0–3.5)0.420Activity level3.3 (2.3–3.7)3.2 (2.2–3.7)3.7 (3.0–4.0)0.029Vigilance3.3 (2.7–3.7)3.3 (2.7–3.7)3.0 (3.0–3.3)0.922Social outcomes3.0 (3.0–4.0)3.0 (2.0–4.0)4.0 (3.0–4.0)0.269Intimacy and sexual relationships3.0 (2.0–4.0)3.5 (2.0–4.0)3.0 (1.0–4.0)0.381Mean FOSQ score3.3 (2.8–3.7)3.3 (2.8–3.6)3.2 (2.8–3.8)0.718Total FOSQ score16.3 (14.0–18.3)16.3 (13.8–18.2)16.0 (14.0–18.8)0.718aMedian (IQR)*Wilcoxon rank-sum testFOSQ-10 10-item Functional Outcomes of Sleep Questionnaire Pretreatment FOSQ-10 scores (n = 61) aMedian (IQR) *Wilcoxon rank-sum test FOSQ-10 10-item Functional Outcomes of Sleep Questionnaire There were no significant sex differences across most FOSQ-10 domains (p > 0.05), with the exception of activity level, where female patients scored significantly higher than their male counterparts (p = 0.029). Multivariate analysis, employing a generalized linear model (GLM) with a gamma distribution identified factors that were independently associated with specific FOSQ-10 domains. The selection of variables for these models was informed by the initial univariate analyses, as shown in Fig. 2. Demographic and polysomnographic factors demonstrating statistical significance or clinical relevance (such as age, AHI, and sex) were included to assess their independent influence while controlling for confounders. To ensure model robustness and prevent multicollinearity, the obstructive apnea index and hypopnea index were excluded because of their high correlation with other primary measures.Fig. 2Forest plot illustrating the results of separate univariate generalized linear models (GLMs) assessing associations between demographic and polysomnographic variables and FOSQ-10 components. No adjustment for multiple comparisons was applied. Different x-axis scales were used for FOSQ_Act to accommodate Sex variance. FOSQ-10 10-item Functional Outcomes of Sleep Questionnaire; FOSQ-10 components: FOSQ_GProd general productivity, FOSQ_Intim intimacy and sexual relationships, FOSQ_Soc social outcomes, FOSQ_Vig vigilance, FOSQ_Act activity level, FOSQ_Mean average of five components, FOSQ_Total sum of five components Forest plot illustrating the results of separate univariate generalized linear models (GLMs) assessing associations between demographic and polysomnographic variables and FOSQ-10 components. No adjustment for multiple comparisons was applied. Different x-axis scales were used for FOSQ_Act to accommodate Sex variance. FOSQ-10 10-item Functional Outcomes of Sleep Questionnaire; FOSQ-10 components: FOSQ_GProd general productivity, FOSQ_Intim intimacy and sexual relationships, FOSQ_Soc social outcomes, FOSQ_Vig vigilance, FOSQ_Act activity level, FOSQ_Mean average of five components, FOSQ_Total sum of five components As presented in Table 3, age was significantly and positively associated with general productivity (effect ratio [ER] = 1.119; p = 0.002), indicating that a higher age was associated with relatively better functional productivity in this sample. In addition, the domains of intimacy and sexual relationships were significantly influenced by both age and OSA severity. Specifically, older age (ER = 0.805; p = 0.008) and an increased apnea–hypopnea index (AHI) (ER = 0.834; p = 0.028) were independently associated with poorer intimacy outcomes.Table 3Multivariate generalized linear model (GLM) identifying factors independently associated with FOSQ-10 functional domainsOutcomes (FOSQ-10)FactorsEffect ratiop-ValueGeneral productivityAge1.1190.002Intimacy and sexual relationshipsAge0.8050.008Intimacy and sexual relationshipsAHI0.8340.028Only statistically significant variables are retained in the final model. The obstructive apnea and hypopnea indices were excluded from this multivariate analysis to avoid multicollinearityAHI apnea–hypopnea index, FOSQ-10 10-item Functional Outcomes of Sleep Questionnaire Table 3Multivariate generalized linear model (GLM) identifying factors independently associated with FOSQ-10 functional domainsOutcomes (FOSQ-10)FactorsEffect ratiop-ValueGeneral productivityAge1.1190.002Intimacy and sexual relationshipsAge0.8050.008Intimacy and sexual relationshipsAHI0.8340.028Only statistically significant variables are retained in the final model. The obstructive apnea and hypopnea indices were excluded from this multivariate analysis to avoid multicollinearityAHI apnea–hypopnea index, FOSQ-10 10-item Functional Outcomes of Sleep Questionnaire Multivariate generalized linear model (GLM) identifying factors independently associated with FOSQ-10 functional domains Only statistically significant variables are retained in the final model. The obstructive apnea and hypopnea indices were excluded from this multivariate analysis to avoid multicollinearity AHI apnea–hypopnea index, FOSQ-10 10-item Functional Outcomes of Sleep Questionnaire Psychological Distress (DASS-21) and the FOSQ–DASS Interrelationship A high prevalence of psychological distress was observed (Table 4). Using established cutoffs for moderate-to-severe symptoms, 54.1% of the patients experienced clinically significant anxiety, followed by depression (22.9%) and stress (18.0%).Table 4Psychological distress profiles via DASS-21 (n = 61)DASS-21 componentsTotal (N = 61)*Male (N = 48)aFemale (N = 13)ap-Value*Prevalence, %(≥ moderate)Depression2.0 (0.0–12.0)2.0 (0.0–10.0)6.0 (2.0–14.0)0.31522.9%Anxiety10.0 (4.0–14.0)10.0 (4.0–12.0)12.0 (4.0–14.0)0.69054.1%Stress10.0 (2.0–16.0)10.0 (2.0–16.0)8.0 (6.0–18.0)0.59018.0%aMedian (Q1−Q3)*Wilcoxon rank-sum testDASS-21 21-item Depression, Anxiety, and Stress Scale Table 4Psychological distress profiles via DASS-21 (n = 61)DASS-21 componentsTotal (N = 61)*Male (N = 48)aFemale (N = 13)ap-Value*Prevalence, %(≥ moderate)Depression2.0 (0.0–12.0)2.0 (0.0–10.0)6.0 (2.0–14.0)0.31522.9%Anxiety10.0 (4.0–14.0)10.0 (4.0–12.0)12.0 (4.0–14.0)0.69054.1%Stress10.0 (2.0–16.0)10.0 (2.0–16.0)8.0 (6.0–18.0)0.59018.0%aMedian (Q1−Q3)*Wilcoxon rank-sum testDASS-21 21-item Depression, Anxiety, and Stress Scale Psychological distress profiles via DASS-21 (n = 61) aMedian (Q1−Q3) *Wilcoxon rank-sum test DASS-21 21-item Depression, Anxiety, and Stress Scale Psychological distress profiles, including depression, anxiety, and stress scores, remained comparable between male and female patients (p > 0.05). Spearman’s analysis revealed significant negative correlations between the FOSQ-10 and DASS-21 dimensions (Fig. 3). Stress showed the largest negative correlation with the total FOSQ score (moderate level, rho = −0.43, p < 0.001), followed by depression (rho = −0.39, p < 0.01). FOSQ vigilance and general productivity showed consistent but moderate negative correlations across all psychological domains. In contrast, activity level and intimacy were not significantly associated (p > 0.05). Overall, higher psychological problems, particularly stress, were moderately associated with poorer daytime functioning in patients with OSA.Fig. 3Heatmap illustrating Spearman’s correlation coefficients (rho) between FOSQ-10 functional domains and DASS-21 psychological components. Significance levels: *p < 0.05, **p < 0.01, ***p < 0.001. FOSQ-10 10-item Functional Outcomes of Sleep Questionnaire, DASS-21 21-item Depression, Anxiety, and Stress Scale Heatmap illustrating Spearman’s correlation coefficients (rho) between FOSQ-10 functional domains and DASS-21 psychological components. Significance levels: *p < 0.05, **p < 0.01, ***p < 0.001. FOSQ-10 10-item Functional Outcomes of Sleep Questionnaire, DASS-21 21-item Depression, Anxiety, and Stress Scale Discussion Demographic and Polysomnographic Characteristics The mean age of patients in our study was 47.8 ± 12.9 years. This distribution aligns with the established clinical understanding that OSA prevalence increases with age because of structural changes in the airway and the accumulation of metabolic risk factors. Furthermore, the significant male predominance (78.7%) observed in our population—nearly four times that of female participants—is consistent with international literature citing anatomical differences in the pharynx, hormonal influences, and lifestyle factors as key drivers of this sex disparity. The significantly higher AHI and T90 levels observed in male patients suggest that men in this population experienced more severe airway obstruction and prolonged nocturnal hypoxemia than women. This disparity may be partly attributed to the significantly larger neck circumference found in the male group, a well-recognized anatomical risk factor for increased upper airway collapsibility. These findings align with the existing literature, indicating that men often present with a more severe clinical phenotype of OSA [14–16]. As the University Medical Center Ho Chi Minh City is a tertiary referral center at the top of the healthcare hierarchy in Southern Vietnam, it primarily manages patients with complex or severe symptoms who have been referred from primary or secondary care facilities. It explains the high proportion of severe OSA (70.5%) in our patient sample. Anthropometric measurements further underscore the metabolic burden in this population. The mean body mass index (BMI) falls within the obese range, complemented by elevated neck and waist circumferences. These findings reinforce the role of central and cervical adiposity as confirmed risk factors for OSA, as fat deposition in these regions promotes upper airway narrowing and reduces ventilatory capacity. Comorbidities Our findings confirm a high burden of comorbidities among Vietnamese patients with OSA, particularly cardiovascular and metabolic disorders. Gastroesophageal reflux disease (GERD) and dyslipidemia were the most prevalent, affecting 54.1% and 50.8% of the population, respectively. The high prevalence of dyslipidemia as a primary metabolic dysfunction in patients with OSA, along with the potential for GERD to exacerbate OSA symptoms, has been well documented in domestic and international reports [14, 17]. Functional Outcomes and OSA Daytime sleepiness and its impact on quality of life, as measured by the FOSQ-10, revealed significant impairment in our study population. The median total FOSQ score was 16.3 (IQR: 14.0–18.3). Although the upper quartile exceeded the normal threshold, the median value remained notably below the normal cutoff value of 17.9, suggesting that most participants had clinically functional impairment. The absence of significant sex differences across most domains shows that OSA has similar functional effects in men and women. However, the higher activity level scores observed in female participants may reflect sex-specific differences in perceived or reported daytime functioning; women in this population reported better preservation of activity-related quality of life. Our results are comparable with those of several international studies. For instance, Chaiyaporn-tanarat et al. [3] reported a similar mean FOSQ-10 score of 15.1 ± 2.7 in a Thai OSA population. In the Western context, Soose et al. [4] found a baseline FOSQ score of 14.3 among patients in the USA and Europe, which later improved to over 17.0 following effective treatment. Interestingly, while Xu et al. [6] reported post-intervention improvements in China, our baseline functional impairment appears more severe than that observed in a Swedish population by Veje et al.[5], where patients with OSA maintained a median score of 18.1. These disparities suggest that functional quality of life associated with daytime sleepiness may serve as a critical clinical marker for OSA screening within the community. Multivariate GLM analysis revealed contrasting roles of age across functional domains. Interestingly, advancing age was significantly associated with higher general productivity (ER = 1.119), suggesting that older patients possess better compensatory mechanisms or lower professional demands than younger subjects, probably due to the naturally declining sleep needs of older adults. Conversely, intimacy was negatively influenced by both advancing age (ER = 0.805) and increased AHI (ER = 0.834). This highlights the dual burden of physiological aging and OSA on sexual health. However, we found no significant correlation between nocturnal hypoxemia parameters (T90 and nadir SpO2) and FOSQ-10 scores, suggesting that the functional impact of OSA is not a simple linear consequence of oxygen desaturation. These analyses were exploratory and not adjusted for multiple comparisons, and thus should be interpreted cautiously. Psychological Distress and the FOSQ–DASS Interrelationship A striking finding of this study is the severe psychological burden, specifically the 54.1% prevalence of moderate-to-severe anxiety. This rate is significantly higher than the self-reported history of anxiety (19.7%) and depression (6.6%) provided by patients, suggesting a high proportion of undiagnosed and untreated psychological distress within the OSA population. The psychological burden associated with OSA does not significantly differ by sex within the studied population. Chronic sleep disruption, intermittent hypoxia, and sympathetic overactivation are likely mechanisms contributing to heightened emotional arousal. The consistent negative correlation observed between the FOSQ-10 domains and DASS-21 components indicates that as daytime functional impairment worsens, psychological symptoms become more severe. The results showed that stress had the strongest (yet moderate) association with quality of life (rho = −0.43). This suggests that in clinical management, stress-reducing interventions (such as behavioral therapy) may be an important factor to consider when addressing daytime functional impairment than focusing solely on depressive symptoms. The differences between significant (vigilance and productivity) and insignificant (activity and intimacy) domains indicate that negative psychological states appeared to be more closely associated with cognitive-related domains than physical domains. The fact that the intimacy and sexual domain was not statistically significant may reflect cultural barriers. In the context of research in Vietnam, patients often tend to avoid or underestimate sexual issues in self-administered questionnaires, leading to underreporting and resulting in correlations that are not significant. Our study demonstrated a consistent negative correlation between the FOSQ-10 domains and DASS-21 components, reflecting the intricate link between sleep-related functional impairment and mental health in patients with OSA. Although direct investigations specifically correlating the FOSQ-10 with the DASS-21 are currently lacking in literature, our findings align with established research observing the relationship between sleep-related quality of life and broader psychological constructs. The FOSQ-10 has demonstrated significant correlations with other validated psychological and quality-of-life instruments, including the 36-item Short Form Health Survey (SF-36) and the Zung Self-Rating Depression Scale [18, 19]. These associations provide precedents for the intersection of functional outcomes and emotional well-being. The choice of the DASS-21 in our study is further supported by its high convergent validity with other specialized tools. For instance, in telemental health settings, the DASS-21 depression and anxiety subscales have shown strong correlations with the Patient Health Questionnaire-8 (PHQ-8) and the General Anxiety Disorder-7 (GAD-7) scale, with coefficients of r = 0.71 and r = 0.61, respectively [19]. Furthermore, numerous psychometric analyses have confirmed the robust three-factor structure of the DASS-21, encompassing depression, anxiety, and stress. This structure allows the instrument to effectively capture “general psychological distress” in both community-based and clinical populations. The consistent negative associations observed in our study population (ranging from rho = −0.11 to −0.43) suggest that the functional decline captured by the FOSQ-10, particularly in areas such as general productivity and stress management, may reflect aspects of broader psychological distress. This reinforces the clinical value of using the DASS-21 as a screening tool to identify patients in whom daytime functioning is most severely compromised by their underlying emotional state. Although insomnia symptoms are increasingly recognized as an important comorbidity in patients with OSA, the present study did not include a dedicated assessment of insomnia (e.g., using the Insomnia Severity Index [ISI]). In our study, polysomnographic parameters such as total sleep time and sleep efficiency were generally comparable to those reported in Vietnamese populations without clinically significant insomnia [14], suggesting that marked insomnia symptoms may not have been prominent in this sample. Nevertheless, the coexistence of insomnia and OSA, often referred to as COMISA, has been associated with greater impairment in daytime functioning and poorer mental health outcomes [20]. This highlights the importance of incorporating insomnia-specific assessments in future studies to better characterize the overall psychological burden in patients with OSA. Study Limitations There are a few limitations that should be taken into account. First, the cross-sectional design prevents establishing causal relationships between OSA and functional outcomes or psychological distress. Second, as a single-center study with a limited sample size and the majority of patients being male and having severe OSA, the results may not be fully representative of the entire Vietnamese OSA population. Additionally, external factors, such as socioeconomic status or social support, as well as insomnia symptoms (which were not formally assessed using instruments such as the ISI), were not accounted for, and the reliance on self-reported scales (FOSQ-10 and DASS-21) introduces the possibility of reporting bias. Clinical Implications These findings highlight the necessity of a multidimensional assessment besides AHI. Clinical factors, symptom presentation, and individual psychological characteristics may influence the relationship between sleep-related functional outcomes and symptoms of depression, anxiety, and stress. A better understanding of these factors may help guide more tailored and appropriate interventions. Furthermore, the high prevalence of undiagnosed anxiety and depression suggests the need for integrated care models that combine medical treatment with psychological interventions to optimize overall patient outcomes. Conclusions This study shows that untreated Vietnamese patients with OSA experience significant functional impairment and heightened psychological distress. More than half of the study sample (54.1%) had clinically significant anxiety. The persistent negative connection between all FOSQ-10 domains and DASS-21 components, especially stress and overall functional quality of life, shows that OSA affects more than nocturnal respiratory episodes. A patient’s subjective experience of daytime sleepiness and functional deterioration may indicate their psychological resiliency and mental well-being. Age and AHI were also related to certain functional areas such as productivity and intimacy, emphasizing the necessity for individualized therapy interventions. Comprehensive assessments are needed to identify functional impairment and psychological disorders to improve the quality of life and well-being of patients with OSA.